| University Hospitals Performing Same Or Similar Procedures |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Contact brian@allyoumed.com |
Clinical Trial: NCT00273364
Stem Cell Therapy for Patients With Multiple Sclerosis
Failing Interferon A Randomized Study
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control,
Crossover Assignment, Safety/Efficacy Study
Official Title: Hematopoietic Stem Cell Therapy for Patients With
Inflammatory Multiple Sclerosis Failing Interferon: As a randomized study,
autologous unmanipulated PBSCT using a conditioning regimen of
cyclophosphamide and rATG
Locations
United States, Illinois Recruiting
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States, 60611
Contact: Dzemila Spahovic, MD 312-908-0059
d-spahovic@northwestern.edu
Principal Investigator: Richard Burt, MD
---------------------------------------------------------------------------------------------------------
http://www.clinicaltrials.gov/ct/show/NCT00288626
High-Dose Immunosuppression and Autologous
Transplantation for Multiple Sclerosis (HALT MS) Study
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled,
Single Group Assignment, Safety/Efficacy Study
Official Title: A Phase II Study of High-Dose Immunosuppressive
Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan
(BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem
Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple
Sclerosis
Locations
United States, California
City of Hope National Medical Center Recruiting
Duarte, California, United States, 91010
Contact: Emily Krupka, RN, BSN 626-256-4673 ext 64658
ekrupka@coh.org
Principal Investigator: Stephen J. Forman, MD
Principal Investigator: Harry Openshaw, MD
United States, Texas
University of Texas - Southwestern Recruiting
Dallas, Texas, United States, 75390-9036
Contact: Olaf Stuve, MD 214-648-2330
olaf.stuve@utsouthwestern.edu
Principal Investigator: Olaf Stuve, MD
M.D. Anderson Cancer Center Recruiting
Houston, Texas, United States, 77230-1402
Contact: Marilyn S. Davis, RN, CCRC 713-745-4371
msdavis@mdanderson.org
Principal Investigator: Uday Popat, MD
Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: George J. Hutton, MD 713-798-8170
ghutton@bcm.tmc.edu
Principal Investigator: George J. Hutton, MD
United States, Washington
Fred Hutchinson Cancer Research Center Recruiting
Seattle, Washington, United States, 98109-1024
Contact: Bernie McLaughlin, RN 206-667-4916
bmclaugh@fhcrc.org
Principal Investigator: James Bowen, MD
Principal Investigator: Richard Nash, MD
---------------------------------------------------------------------------------------------------------
Other possible institutions that may be doing similar procedures, but not
listed on ClinicalTrials.gov. I will add to the list as I can find and verify them.
Vanderbilt University Medical Center, Nashville, Tennessee
University of Colorado at Denver Health Science Center, Aurora
University of North Carolina, Chapel Hill
University of Colorado at Denver Health Science Center, Denver
University of Massachusetts Memorial Medical Center and Medical
School, Worcester
VA Salt Lake City Health Care System, Salt Lake City, Utah
University of California, Los Angeles
Stem Cell Therapy for Patients With Multiple Sclerosis
Failing Interferon A Randomized Study
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control,
Crossover Assignment, Safety/Efficacy Study
Official Title: Hematopoietic Stem Cell Therapy for Patients With
Inflammatory Multiple Sclerosis Failing Interferon: As a randomized study,
autologous unmanipulated PBSCT using a conditioning regimen of
cyclophosphamide and rATG
Locations
United States, Illinois Recruiting
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States, 60611
Contact: Dzemila Spahovic, MD 312-908-0059
d-spahovic@northwestern.edu
Principal Investigator: Richard Burt, MD
---------------------------------------------------------------------------------------------------------
http://www.clinicaltrials.gov/ct/show/NCT00288626
High-Dose Immunosuppression and Autologous
Transplantation for Multiple Sclerosis (HALT MS) Study
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled,
Single Group Assignment, Safety/Efficacy Study
Official Title: A Phase II Study of High-Dose Immunosuppressive
Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan
(BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem
Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple
Sclerosis
Locations
United States, California
City of Hope National Medical Center Recruiting
Duarte, California, United States, 91010
Contact: Emily Krupka, RN, BSN 626-256-4673 ext 64658
ekrupka@coh.org
Principal Investigator: Stephen J. Forman, MD
Principal Investigator: Harry Openshaw, MD
United States, Texas
University of Texas - Southwestern Recruiting
Dallas, Texas, United States, 75390-9036
Contact: Olaf Stuve, MD 214-648-2330
olaf.stuve@utsouthwestern.edu
Principal Investigator: Olaf Stuve, MD
M.D. Anderson Cancer Center Recruiting
Houston, Texas, United States, 77230-1402
Contact: Marilyn S. Davis, RN, CCRC 713-745-4371
msdavis@mdanderson.org
Principal Investigator: Uday Popat, MD
Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: George J. Hutton, MD 713-798-8170
ghutton@bcm.tmc.edu
Principal Investigator: George J. Hutton, MD
United States, Washington
Fred Hutchinson Cancer Research Center Recruiting
Seattle, Washington, United States, 98109-1024
Contact: Bernie McLaughlin, RN 206-667-4916
bmclaugh@fhcrc.org
Principal Investigator: James Bowen, MD
Principal Investigator: Richard Nash, MD
---------------------------------------------------------------------------------------------------------
Other possible institutions that may be doing similar procedures, but not
listed on ClinicalTrials.gov. I will add to the list as I can find and verify them.
Vanderbilt University Medical Center, Nashville, Tennessee
University of Colorado at Denver Health Science Center, Aurora
University of North Carolina, Chapel Hill
University of Colorado at Denver Health Science Center, Denver
University of Massachusetts Memorial Medical Center and Medical
School, Worcester
VA Salt Lake City Health Care System, Salt Lake City, Utah
University of California, Los Angeles
This is a list of University Hospitals that may perform the procedure
outside of the study. Click the Clinical Trials links to further research the
procedures.
--------------------------------------------------------------------------------------------------------
outside of the study. Click the Clinical Trials links to further research the
procedures.
--------------------------------------------------------------------------------------------------------
